Christoph Brönnimann
Chief Executive Officer bei MEDARTIS HOLDING AG
Vermögen: 3 Mio $ am 31.03.2024
Profil
Christoph Brönnimann is currently the Chief Executive Officer at Medartis Holding AG and Medartis AG.
He is also a Director at Johnson & Johnson Foundation Scotland and Keri Medical SA. In the past, he worked as a Product Manager at Roche Vitamins, Inc. from 1995 to 2000 and as the General Manager-Switzerland at DePuy Synthes, Inc. from 2005 to 2012.
Dr. Brönnimann holds a doctorate degree from the Swiss Federal Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MEDARTIS HOLDING AG
0,26% | 31.12.2022 | 31 847 ( 0,26% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Christoph Brönnimann
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDARTIS HOLDING AG | Chief Executive Officer | 01.09.2019 |
Johnson & Johnson Foundation Scotland
 Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Director/Board Member | - |
| Medartis AG | Chief Executive Officer | 01.09.2019 |
Keri Medical SA
 Keri Medical SA Medical SpecialtiesHealth Technology Keri Medical SA engages in the development and manufacture of implants for hand and wrist surgery. It trademarks include KeriFix, KeriLock, Motec, Reaxon, and Touch. The company was founded by Bernard Prandi and Dougal Bendjaballah in 2016 and is headquartered in Geneva, Switzerland. | Director/Board Member | - |
Ehemalige bekannte Positionen von Christoph Brönnimann
| Unternehmen | Position | Ende |
|---|---|---|
DePuy Synthes, Inc.
 DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Corporate Officer/Principal | 01.08.2012 |
Roche Vitamins, Inc.
 Roche Vitamins, Inc. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Vitamins, Inc. is an American company. | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Christoph Brönnimann
| Swiss Federal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MEDARTIS HOLDING AG | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Roche Vitamins, Inc.
Roche Vitamins, Inc. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Vitamins, Inc. is an American company. | Health Technology |
DePuy Synthes, Inc.
DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Health Technology |
Johnson & Johnson Foundation Scotland
Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Commercial Services |
Keri Medical SA
Keri Medical SA Medical SpecialtiesHealth Technology Keri Medical SA engages in the development and manufacture of implants for hand and wrist surgery. It trademarks include KeriFix, KeriLock, Motec, Reaxon, and Touch. The company was founded by Bernard Prandi and Dougal Bendjaballah in 2016 and is headquartered in Geneva, Switzerland. | Health Technology |
| Medartis AG |
